Pharma Foods International Co., Ltd.

Tokyo Stock Exchange 2929.T

Pharma Foods International Co., Ltd. Capital Expenditure for the year ending July 31, 2024: USD -6.49 M

Pharma Foods International Co., Ltd. Capital Expenditure is USD -6.49 M for the year ending July 31, 2024, a -128.04% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Pharma Foods International Co., Ltd. Capital Expenditure for the year ending July 31, 2023 was USD -2.85 M, a 19.65% change year over year.
Pharma Foods International Co., Ltd. Capital Expenditure for the year ending July 31, 2022 was USD -3.54 M, a -124.61% change year over year.
Pharma Foods International Co., Ltd. Capital Expenditure for the year ending July 31, 2021 was USD -1.58 M, a 81.71% change year over year.
Pharma Foods International Co., Ltd. Capital Expenditure for the year ending July 31, 2020 was USD -8.62 M, a -234.25% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

Tokyo Stock Exchange: 2929.T

Pharma Foods International Co., Ltd.

CEO	Mr. Mu Jo Kim
IPO Date	June 12, 2006
Location	Japan
Headquarters	1-49 Goryo-Ohara
Employees	642
Sector	Health Care
Industries Pharmaceuticals Biotechnology Consumer Packaged Goods

Description

Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. Its products include Pharma-GABA, Bonepep, Ovopron (egg yolk globulin), Delicious Catechin, RunPep, and enriched Folic Acid Egg, as well as iHA, a substance that stimulates secretion of hyaluronic acid. Pharma Foods International Co., Ltd. has licensing agreement with Mitsubishi Tanabe Pharma Corporation for a new therapeutic antibody to treat autoimmune diseases. Pharma Foods International Co., Ltd. was founded in 1997 and is based in Kyoto, Japan.

Key trends

Past 5 years